Business
Moderna CEO sees virus vaccine interim data in November: Report – Aljazeera.com
US drugmaker’s CEO says Washington could approve vaccine for emergency use in December, Wall Street Journal reports.
Moderna Incs Chief Executive Officer Stephane Bancel expects interim results from its coronavirus vaccine trial in November and that the United States government could approve the drug for emergency use in December, the Wall Street Journal newspaper reported.
Speaking at the newspapers annual Tech Live conference, Bancel also said on Monday that if sufficient interim results from the study are delayed, government permission to use the vaccine may not come until next year.
The first interim ana…
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News18 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News20 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News21 hours agoCountdown on for Noosa Eat & Drink Festival 2025